| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 09/14/1994 | EP0614357A1 Immunopotentiatory agents |
| 09/14/1994 | EP0614355A1 Antitumor vaccines |
| 09/14/1994 | EP0518960B1 Derivatives of n-phenyl glycinamide, their preparation and medicaments containing them |
| 09/14/1994 | CN1092072A Pharmaceutical compounds |
| 09/13/1994 | US5346917 Thioxanthenone antitumor agents |
| 09/13/1994 | US5346915 Chromans and thiochromans with phenylethynyl substituents at the 7-position having retinold-like biological activity |
| 09/13/1994 | US5346912 2-cyano-3-hydroxy-(n-pyridyl)-propenamide compounds |
| 09/13/1994 | US5346894 Treatment of lyso PAF-mediated diseases with PAF antagonists and procedure for determining their efficacy |
| 09/13/1994 | US5346696 Recombinent Interferon |
| 09/12/1994 | CA2118867A1 2-debenzoyl-2-acyl taxol derivatives and methods for making same |
| 09/12/1994 | CA2117116A1 Cell differentiation inducer comprising acyclic polyisoprenoid |
| 09/10/1994 | CA2118558A1 Soluble human fc-gamma iii receptors, process for the preparation thereof, pharmaceutical compositions containing same, utilization thereof as medicaments, and diagnostic application thereof |
| 09/09/1994 | CA2117122A1 Benzoxazine derivatives, their preparation, and their application in therapy |
| 09/07/1994 | EP0613945A2 Tumor suppressor gene merlin and uses thereof |
| 09/07/1994 | EP0613944A2 Methods for regulating the immune response using CTLA4-binding molecules and IL4-binding molecules |
| 09/07/1994 | EP0613687A1 Use of a pregnane derivatives for the treatment of tumours |
| 09/07/1994 | EP0613478A1 Immunostimulating swainsonine analogs |
| 09/07/1994 | EP0613477A1 Triazine derivatives for enhancing antitumor activity |
| 09/07/1994 | EP0613379A1 Therapeutic compounds |
| 09/07/1994 | EP0613375A1 Pharmaceutical lysine-containing polypeptide compositions and methods of use thereof |
| 09/07/1994 | EP0613373A1 Risedronate delayed-release compositions |
| 09/07/1994 | EP0563127B1 Improved treatment method for cancer |
| 09/07/1994 | EP0485583B1 Use of tetrahydroisoquinoline derivatives for preparing antitumoral drugs |
| 09/07/1994 | CN1091745A Anti-proliferative and anti-inflammatory compounds: derivatives of pentose monosaccharides |
| 09/07/1994 | CN1091742A 水溶性喜树碱衍生物 Water-soluble derivative of camptothecin |
| 09/06/1994 | US5344938 Antitumor |
| 09/06/1994 | US5344841 Bis-(hydroxylakylamino)-anthraquinone inhibitors of protein kinase C |
| 09/06/1994 | US5344834 Functionalized vinyl azoles and methods of use |
| 09/06/1994 | US5344827 Anticarcinogenic agents |
| 09/01/1994 | WO1994019466A2 A novel family of anti-carcinoembryonic antigen chimeric antibodies |
| 09/01/1994 | WO1994019457A1 Human b-lymphoblastoid cell line secreting anti-ganglioside antibody |
| 09/01/1994 | WO1994019352A1 Meso-tetraphenyl porphyrin complex compounds, process for preparing the same and pharmaceuticals containing the same |
| 09/01/1994 | WO1994019350A1 Pyrazolitriazines with interleukin-1 and tumour necrosis factor inhibitory activity |
| 09/01/1994 | WO1994019332A1 Retroviral protease inhibiting compounds |
| 09/01/1994 | WO1994019022A1 Composition for use in the treatment of tumours and the immunization of humans and animals |
| 09/01/1994 | WO1994019004A1 Ligand antagonists for treatment of breast cancer |
| 09/01/1994 | WO1994018999A1 A mutant protein and methods and materials for making and using it |
| 09/01/1994 | WO1994018992A1 Cytopathic viruses for therapy and prophylaxis of neoplasia |
| 09/01/1994 | WO1994018990A1 Combination cisplatin/tamoxifen therapy for human cancers |
| 09/01/1994 | WO1994018986A1 Use of oligosaccharide glycosides as inhibitors of bacterial adherence |
| 09/01/1994 | WO1994018961A1 Cancer treatment |
| 09/01/1994 | WO1994016069A3 Ras associated gap proteins |
| 09/01/1994 | WO1993012756A3 Transfection of lung via aerosolized transgene delivery |
| 09/01/1994 | CA2157049A1 Use of oligosaccharide glycosides as inhibitors of bacterial adherence |
| 09/01/1994 | CA2156919A1 Pyrazolitriazines with interleukin-1 and tumour necrosis factor inhibitory activity |
| 09/01/1994 | CA2156826A1 Combination cisplatin/tamoxifen therapy for human cancers |
| 09/01/1994 | CA2156635A1 Composition useful for the treatment of tumors and immunization of organisms against tumors |
| 09/01/1994 | CA2156158A1 Meso-tetraphenyl porphyrin complex compounds, process for preparing the same and pharmaceuticals containing the same |
| 09/01/1994 | CA2155934A1 A novel family of anti-carcinoembryonic antigen chimeric antibodies |
| 09/01/1994 | CA2155338A1 Retroviral protease inhibiting compounds |
| 08/31/1994 | EP0613006A1 Antibodies to cachectin and immunoassays |
| 08/31/1994 | EP0612763A1 Cyclic derivatives of angiopeptin, their preparation and their pharmaceutical compositions |
| 08/31/1994 | EP0612762A1 Elucidation and synthesis of selected pentapeptides |
| 08/31/1994 | EP0612760A2 Method for purification of estramustin phosphate or salt thereof |
| 08/31/1994 | EP0612742A1 A physiologically active bisindole-pyrrole derivative |
| 08/31/1994 | EP0612741A1 Cyclic derivatives, medicaments containing them and process for their preparation |
| 08/31/1994 | EP0612723A1 Substituted benzoylguanidines, process for their preparation, their use as medicament, as inhibitor of the cellular Na+/H+ exchange or as diagnostic agent and medicament containing them |
| 08/31/1994 | EP0612530A2 Pharmaceutical preparations containing tumor cytotoxic factor |
| 08/31/1994 | EP0612248A1 Combination chemotherapy |
| 08/31/1994 | EP0612246A1 Pharmaceutical compositions of gallium complexes of 3-hydroxy-4-pyrones |
| 08/30/1994 | US5342925 Radioactive compositions for soft tissue tumors |
| 08/30/1994 | US5342774 Nucleotide sequence encoding the tumor rejection antigen precursor, MAGE-1 |
| 08/30/1994 | US5342757 Monoclonal antibodies which specifically binds to endosialin, a 165 Kd glycoprotein found on tumor vascular endothelium, and uses thereof |
| 08/30/1994 | US5342615 Method for treating arthritis or inflammation with Il-1α or derivatives thereof |
| 08/26/1994 | CA2115404A1 Tumor suppressor gene merlin and uses thereof |
| 08/25/1994 | DE4337197C1 Process for the selective preparation of hybridoma cell lines which produce monoclonal antibodies with high cytotoxicity against human CD16 antigen, and the preparation of bispecific monoclonal antibodies using such monoclonal antibodies and the CD30-HRS-3 antibody for therapy of human tumours |
| 08/25/1994 | DE4305388A1 Cyclic derivatives, medicaments containing these compounds and processes for their preparation |
| 08/24/1994 | EP0611775A2 Human cancer inhibitory pentapeptide amides |
| 08/24/1994 | EP0611765A1 2-(Imidazol-1-yl)-3-heteroarylpropylidene-aminoxyalkanoic acid derivatives |
| 08/24/1994 | EP0611660A2 Condensed 5-membered heterocycles, process for their preparation and medicines containing these compounds |
| 08/24/1994 | EP0611372A1 Photosensitizers |
| 08/24/1994 | EP0611304A1 Uses of aloe products, e.g. acemannan, in the treatment of diseases requiring intervention of the immune system for cure |
| 08/24/1994 | EP0611303A1 PREPARATIONS CONTAINING Carboplatin or Lobaplatin FOR ANTI-TUMOUR THERAPY AND/ OR STIMULATING THE HAEMATOPOIETIC SYSTEM |
| 08/24/1994 | EP0506794B1 Novel vitamin d analogues |
| 08/24/1994 | EP0478631B1 Targetting agents |
| 08/24/1994 | EP0423214B1 Purification and administration of dna repair enzymes |
| 08/24/1994 | CN1091139A PTP-D subfamily of protein tyrosine phosphatases |
| 08/24/1994 | CN1091005A Immunopotentiatory agents and physiologically acceptable salts thereof |
| 08/24/1994 | CN1025735C Process for preparing isothiocyanato functionalized metal complexes |
| 08/23/1994 | US5340833 Urokinase inhibitors |
| 08/23/1994 | US5340828 Anticarcinogenic agents |
| 08/23/1994 | US5340565 Tumor or cancer cell killing therapy and agents useful therefor |
| 08/23/1994 | CA2116193A1 Physiologically active compound hs-1 and process for the preparation of the same |
| 08/23/1994 | CA2116068A1 Cyclic derivatives, pharmaceutical compositions containing these compounds and processes for preparing them |
| 08/23/1994 | CA2115972A1 Cyclopeptide derivatives of angiopeptin, process for the preparation thereof and pharmaceutical compositions containing same |
| 08/21/1994 | CA2115967A1 Substituted benzoylguanidines, process for their preparation, their use as a pharmaceutical, as inhibitors of the cellular na+/h+exchange or as a diagnostic, and pharmaceutical containing them |
| 08/21/1994 | CA2115966A1 Chrysospermins, active peptides from apiocrea chrysosperma having a pharmacological effect, a process for their preparation and the use thereof |
| 08/18/1994 | WO1994018562A1 Human carcinoma antigen (hca), hca antibodies, hca immunoassays, methods of imaging and therapy |
| 08/18/1994 | WO1994018222A1 Nuclear matrix proteins |
| 08/18/1994 | WO1994018208A1 7,42-bis (o-demethyl) rapamycin |
| 08/18/1994 | WO1994018206A1 Rapamycin derivative process for its preparation and its use |
| 08/18/1994 | WO1994018171A1 Unsymmetrical bis-imides as anticancer agents |
| 08/18/1994 | WO1994018151A1 Acylfulvene analogues as antitumor agents |
| 08/18/1994 | WO1994017815A1 Therapeutic compounds derived from the neem tree |
| 08/18/1994 | WO1994017773A2 Use of a pharmaceutical composition comprising an effective amount of interleukin-10, an analog and/or an agonist of interleukin-10 |
| 08/18/1994 | WO1994011026A3 Therapeutic application of chimeric and radiolabeled antibodies to human b lymphocyte restricted differentiation antigen for treatment of b cell lymphoma |
| 08/18/1994 | DE4311580C1 Glycoproteins, process for their preparation and pharmaceutical compositions containing them |
| 08/18/1994 | CA2155856A1 Unsymetrical bis-imides as anticancer agents |
| 08/18/1994 | CA2155645A1 Nuclear matrix proteins |
| 08/18/1994 | CA2155109A1 Use of a pharmaceutical composition comprising an effective amount of interleukin-10, an analog and/or an agonist of interleukin-10 |